EICOSANOID MODULATION IN RAT RENAL ALLOGRAFT REJECTION
EICOSANOID MODULATION IN RAT RENAL ALLOGRAFT REJECTION
批准号:
3463528
负责人:
MARTIN D JENDRISAK
金额:
$9.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-08-01 至 1993-07-31
关键词:
arachidonate cell mediated lymphocytolysis test cellular immunity dendritic cells disease /disorder model dyes eicosanoid metabolism high performance liquid chromatography histocompatibility immunopharmacology immunosuppression kidney function kidney transplantation laboratory rat lipoxygenase mixed lymphocyte reaction test prostaglandin endoperoxide synthase radioimmunoassay
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Renal allografts undergoing acute rejection demonstrate
augmented metabolism of arachidonic acid (AA) to form a variety
of cyclooxygenase (CO) and lipoxygenase (LO) products. These
products of AA metabolism, or eicosanoids, exert powerful
effects on net renal function as well as directly on the immune
system (initial pilot studies in the mouse model). This proposal
investigates the role of altered eicosanoid production on immune
cell function during renal allograft rejection in the rat model with
the specific aim that a novel form of controlled
immunosuppression can be achieved. Additionally, a new concept
is proposed whereby an efficient means of mesangial dendritic
cell depletion from donor renal tissue can be accomplished via
pharmacologic manipulation a AA metabolism prior to
allotransplantation. The relationship between localization of
these resident leukocytes and eicosanoid production has been
demonstrated but remains incompletely understood. The effects
of alterations in AA metabolism directly upon immune active
cells in the rat spleen will initially be studied by lectin
proliferation assays, cell mediated cytotoxicity assays, mixed
lymphocyte reactions, and interleukin-2 production. Using a rat
renal allograft mode, similar immunologic studies as well as
subset analysis of graft infiltrating cells will be performed.
Qualitative and quantitative changes in AA metabolism will be
monitored by RP-HPLC profiles of radiolabeled products derived
from 3H-AA substrate and radioimmunoassay, respectively. The
strategy will be to inhibit "pro-rejection" eicosanoids (TXA2, LO
products) and enhance "anti-rejection" eicosanoids PGI2, PGE2) by
administering compounds which alter AA metabolism either alone
or in combination. It is hypothesized that controlled alterations
in AA metabolism can yield a controlled downregulation of the
rejection response with improvement in allograft survival.
Correlations of alterations in immune cell function through
manipulations in eicosanoid production may enhance our
understanding of mechanisms involved in acute rejection.
Through this unique model of altered AA metabolism, the role of
donor tissue dendritic cells can also be assessed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EICOSANOID MODULATION IN RAT RENAL ALLOGRAFT REJECTION
-
批准号:3463529
-
项目类别:
-
资助金额:$11.11万
-
财政年份:1988
-
负责人:MARTIN D JENDRISAK
-
依托单位:
EICOSANOID MODULATION IN RAT RENAL ALLOGRAFT REJECTION
-
批准号:3463530
-
项目类别:
-
资助金额:$11.24万
-
财政年份:1988
-
负责人:MARTIN D JENDRISAK
-
依托单位:
EICOSANOID MODULATION IN RAT RENAL ALLOGRAFT REJECTION
-
批准号:3463526
-
项目类别:
-
资助金额:$9.65万
-
财政年份:1988
-
负责人:MARTIN D JENDRISAK
-
依托单位:
EICOSANOID MODULATION IN RAT RENAL ALLOGRAFT REJECTION
-
批准号:3463527
-
项目类别:
-
资助金额:$9.02万
-
财政年份:1988
-
负责人:MARTIN D JENDRISAK
-
依托单位: